Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study
Objectives:Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling....
Saved in:
Published in | Heart (British Cardiac Society) Vol. 94; no. 6; pp. 730 - 736 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and British Cardiovascular Society
01.06.2008
BMJ BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives:Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling.Design:Prospective cohort study.Setting:Academic hospital in Chicago, USA.Patients:122 patients with STEMI following acute percutaneous reperfusion.Main outcome measures:Death, recurrent myocardial infarction (MI) and heart failure.Methods:Cardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects.Results:Acute infarct size correlated linearly with the initial ESVI (r = 0.69, p<0.001), end-diastolic volume index (EDVI) (r = 0.42, p<0.001) and EF (r = −0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); p = 0.002) and unchanged EDVI (p = 0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); p = 0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m2; p = 0.005).Conclusions:Infarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance. |
---|---|
AbstractList | Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling.
Prospective cohort study.
Academic hospital in Chicago, USA.
122 patients with STEMI following acute percutaneous reperfusion.
Death, recurrent myocardial infarction (MI) and heart failure.
Cardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects.
Acute infarct size correlated linearly with the initial ESVI (r = 0.69, p<0.001), end-diastolic volume index (EDVI) (r = 0.42, p<0.001) and EF (r = -0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); p = 0.002) and unchanged EDVI (p = 0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); p = 0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m(2); p = 0.005).
Infarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance. Objectives: Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling. Design: Prospective cohort study. Setting: Academic hospital in Chicago, USA. Patients: 122 patients with STEMI following acute percutaneous reperfusion. Main outcome measures: Death, recurrent myocardial infarction (MI) and heart failure. Methods: Cardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects. Results: Acute infarct size correlated linearly with the initial ESVI (r = 0.69, p<0.001), end-diastolic volume index (EDVI) (r = 0.42, p<0.001) and EF (r = −0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); p = 0.002) and unchanged EDVI (p = 0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); p = 0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m2; p = 0.005). Conclusions: Infarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance. Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling.OBJECTIVESEjection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling.Prospective cohort study.DESIGNProspective cohort study.Academic hospital in Chicago, USA.SETTINGAcademic hospital in Chicago, USA.122 patients with STEMI following acute percutaneous reperfusion.PATIENTS122 patients with STEMI following acute percutaneous reperfusion.Death, recurrent myocardial infarction (MI) and heart failure.MAIN OUTCOME MEASURESDeath, recurrent myocardial infarction (MI) and heart failure.Cardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects.METHODSCardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects.Acute infarct size correlated linearly with the initial ESVI (r = 0.69, p<0.001), end-diastolic volume index (EDVI) (r = 0.42, p<0.001) and EF (r = -0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); p = 0.002) and unchanged EDVI (p = 0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); p = 0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m(2); p = 0.005).RESULTSAcute infarct size correlated linearly with the initial ESVI (r = 0.69, p<0.001), end-diastolic volume index (EDVI) (r = 0.42, p<0.001) and EF (r = -0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); p = 0.002) and unchanged EDVI (p = 0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); p = 0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m(2); p = 0.005).Infarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance.CONCLUSIONSInfarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance. Objectives: Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction (STEMI). We sought to assess the relative impact of infarct size, EF and ESVI on clinical outcomes and left ventricular (LV) remodelling. Design: Prospective cohort study. Setting: Academic hospital in Chicago, USA. Patients: 122 patients with STEMI following acute percutaneous reperfusion. Main outcome measures: Death, recurrent myocardial infarction (MI) and heart failure. Methods: Cardiac magnetic resonance imaging was obtained within 1 week following STEMI in 122 subjects. ESVI, EF and infarct size were tested for the association with outcomes over 2 years in 113 subjects, and a repeat study was obtained 4 months later to assess LV remodelling in 91 subjects. Results: Acute infarct size correlated linearly with the initial ESVI (râ[euro]S=â[euro]S0.69, p<0.001), end-diastolic volume index (EDVI) (râ[euro]S=â[euro]S0.42, p<0.001) and EF (râ[euro]S=â[euro]S-0.75, p<0.001). All were independently associated with outcomes (one death, one recurrent MI and 16 heart failure admissions). However, infarct size was the only significant predictor of adverse outcomes (p<0.05) by multivariate analysis. The smallest infarct size tertile had an increased EF (49% (SD 8%) to 53% (6%); pâ[euro]S=â[euro]S0.002) and unchanged EDVI (pâ[euro]S=â[euro]S0.7). In contrast, subjects with the largest infarct tertile also had improved EF (32% (9%) to 36% (11%); pâ[euro]S=â[euro]S0.002) at the expense of a dramatic increase in EDVI (86 (19) to 95 (21) ml/m2 ; pâ[euro]S=â[euro]S0.005). Conclusions: Infarct size, EF and ESVI can predict the development of future cardiac events. Acute infarct size, which is independent of LV stunning and loading, directly relates to LV remodelling and is a stronger predictor of future events than measures of LV systolic performance. |
Author | Tejedor, P Klocke, F J Lee, D C Holly, T A Lloyd-Jones, D Kansal, P Bonow, R O Bucciarelli-Ducci, C Wu, E Ortiz, J T Carr, J C |
Author_xml | – sequence: 1 givenname: E surname: Wu fullname: Wu, E email: ed-wu@northwestern.edu – sequence: 2 givenname: J T surname: Ortiz fullname: Ortiz, J T email: ed-wu@northwestern.edu – sequence: 3 givenname: P surname: Tejedor fullname: Tejedor, P email: ed-wu@northwestern.edu – sequence: 4 givenname: D C surname: Lee fullname: Lee, D C email: ed-wu@northwestern.edu – sequence: 5 givenname: C surname: Bucciarelli-Ducci fullname: Bucciarelli-Ducci, C email: ed-wu@northwestern.edu – sequence: 6 givenname: P surname: Kansal fullname: Kansal, P email: ed-wu@northwestern.edu – sequence: 7 givenname: J C surname: Carr fullname: Carr, J C email: ed-wu@northwestern.edu – sequence: 8 givenname: T A surname: Holly fullname: Holly, T A email: ed-wu@northwestern.edu – sequence: 9 givenname: D surname: Lloyd-Jones fullname: Lloyd-Jones, D email: ed-wu@northwestern.edu – sequence: 10 givenname: F J surname: Klocke fullname: Klocke, F J email: ed-wu@northwestern.edu – sequence: 11 givenname: R O surname: Bonow fullname: Bonow, R O email: ed-wu@northwestern.edu |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20321287$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18070953$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktv1DAUhSNURB-wZocsIVggZerHOM6wQ0OBSiNYUFWIjeXYNx0PiT3YzqjTP8dfw1GGInUBK1_Z3zn3yPeeFkfOOyiK5wTPCGHV-TqkGcVYzAilFaWPihMyr-qSYvLtKNeM87LCTBwXpzFuMMbzRV09KY5JjQVecHZS_Lp0rQo6oWjvADV7pL1LQcWEwK2V02CQVsFYpVGvbhwkq1GA6N34hmxECsUUvLuBgLYBjNXJB-Rb5IekfQ8RpWyDOmgT2kG2tnroVECwAZ2sd6gNaiqyDJwp4z4m3-UuO98NfW7hDNy-zd4-bkfJDnLEtQ85cRrM_mnxuFVdhGeH86y4-nBxtfxUrr58vFy-W5XNfEFTSYTBja7ZXBFgwghDWWWauamM4o1uOddc60pwinkjWJ1vmoZwRjCuiNaMnRWvJ9uc4-cAMcneRg1dpxz4IUqBBWWcigy-fABu_BBcjiaJqHG1yAzJ1IsDNTQ9GLkNtldhL__MJQOvDoCKWnX5k5y28Z6jmFFC67Hd-cTp_D8xQPvXCstxQ2TeEDluiJw2JCv4A4W2SY0TyGO33T905aSzMcHtfRsVfshKMMHl5-ulFJytrr9_Xcj3mX8z8U2_-W-o32LQ4Es |
CitedBy_id | crossref_primary_10_1016_j_jcmg_2014_05_010 crossref_primary_10_1016_j_echo_2021_12_012 crossref_primary_10_1016_j_hlc_2018_02_007 crossref_primary_10_1007_s12410_009_0015_8 crossref_primary_10_1161_CIRCULATIONAHA_113_003653 crossref_primary_10_1186_1471_2261_12_9 crossref_primary_10_1016_j_ijcard_2020_10_052 crossref_primary_10_1016_j_echo_2011_06_002 crossref_primary_10_1016_j_ijcard_2022_09_042 crossref_primary_10_1093_ejechocard_jer163 crossref_primary_10_1016_j_ijcard_2021_11_017 crossref_primary_10_26442_00403660_2022_04_201458 crossref_primary_10_4068_cmj_2020_56_3_180 crossref_primary_10_1148_radiol_2020202132 crossref_primary_10_1093_ehjci_jev129 crossref_primary_10_1161_CIRCEP_110_959544 crossref_primary_10_3389_fcvm_2023_1079647 crossref_primary_10_1016_j_recesp_2016_01_028 crossref_primary_10_13104_imri_2019_23_2_114 crossref_primary_10_1111_j_1445_5994_2011_02606_x crossref_primary_10_1016_j_jacc_2012_02_070 crossref_primary_10_3389_fphys_2021_709230 crossref_primary_10_1002_ccd_25773 crossref_primary_10_4161_biom_24490 crossref_primary_10_1093_ehjci_jeaa175 crossref_primary_10_1002_cnm_3501 crossref_primary_10_1016_j_jbiomech_2013_04_012 crossref_primary_10_1016_j_rec_2010_10_010 crossref_primary_10_1016_j_pcad_2013_01_005 crossref_primary_10_1038_nrcardio_2014_160 crossref_primary_10_1097_HCO_0000000000000227 crossref_primary_10_4068_cmj_2024_60_2_120 crossref_primary_10_1016_j_rec_2010_09_006 crossref_primary_10_1186_s12872_019_1139_7 crossref_primary_10_26442_00403660_2020_04_000571 crossref_primary_10_1007_s10554_015_0657_3 crossref_primary_10_1161_CIRCIMAGING_118_007722 crossref_primary_10_1007_s12410_023_09583_3 crossref_primary_10_1177_2048872613508658 crossref_primary_10_1016_j_jcmg_2009_09_014 crossref_primary_10_1136_heartjnl_2014_306963 crossref_primary_10_1016_j_echo_2022_06_009 crossref_primary_10_1016_j_ihj_2015_03_001 crossref_primary_10_1160_TH16_10_0744 crossref_primary_10_1161_CIRCIMAGING_113_001541 crossref_primary_10_1055_a_2228_7104 crossref_primary_10_1053_j_ro_2011_11_009 crossref_primary_10_1016_j_atherosclerosis_2021_09_019 crossref_primary_10_1161_CIRCRESAHA_118_311217 crossref_primary_10_2459_JCM_0b013e32835f1915 crossref_primary_10_1038_s41598_018_25143_y crossref_primary_10_1177_10760296221137847 crossref_primary_10_1016_j_jacc_2013_11_048 crossref_primary_10_1093_ejcts_ezw213 crossref_primary_10_1186_s12872_018_0767_7 crossref_primary_10_1109_JBHI_2017_2652449 crossref_primary_10_1016_j_amjcard_2009_05_025 crossref_primary_10_1007_s10354_012_0113_0 crossref_primary_10_3390_ijms25021290 crossref_primary_10_1001_jamacardio_2020_0749 crossref_primary_10_1016_j_jacc_2018_09_035 crossref_primary_10_1002_ejhf_2986 crossref_primary_10_1007_s12350_012_9635_5 crossref_primary_10_1007_s13239_011_0066_2 crossref_primary_10_1016_j_ijcard_2009_09_551 crossref_primary_10_1161_CIRCULATIONAHA_108_816512 crossref_primary_10_1007_s11886_021_01464_9 crossref_primary_10_1093_ehjci_jes070 crossref_primary_10_1177_0003319720941723 crossref_primary_10_1016_j_jacc_2010_02_033 crossref_primary_10_1007_s11892_015_0598_1 crossref_primary_10_1177_1074248419869618 crossref_primary_10_3727_096368916X692933 crossref_primary_10_1002_cpt_913 crossref_primary_10_1007_s12410_013_9254_9 crossref_primary_10_1016_j_jacc_2009_06_059 crossref_primary_10_1093_ehjci_jeab244 crossref_primary_10_1161_JAHA_119_014205 crossref_primary_10_1007_s10554_017_1206_z crossref_primary_10_4103_jmisr_jmisr_2_21 crossref_primary_10_1016_j_amjcard_2010_04_012 crossref_primary_10_1371_journal_pone_0263270 crossref_primary_10_1016_j_ahj_2012_06_015 crossref_primary_10_1586_erc_12_102 crossref_primary_10_2217_fca_13_102 crossref_primary_10_1007_s12410_024_09597_5 crossref_primary_10_1016_j_ahj_2008_04_012 crossref_primary_10_1016_j_crad_2016_02_013 crossref_primary_10_1371_journal_pone_0130158 crossref_primary_10_1002_jmri_24494 crossref_primary_10_1016_j_ahj_2014_07_015 crossref_primary_10_1016_j_jbiomech_2014_11_049 crossref_primary_10_1016_j_ijcard_2020_12_006 crossref_primary_10_12998_wjcc_v8_i7_1232 crossref_primary_10_1007_s10554_017_1195_y crossref_primary_10_1016_j_ijcard_2018_03_042 crossref_primary_10_1016_j_cpet_2011_10_002 crossref_primary_10_1007_s12410_011_9071_y crossref_primary_10_1016_j_jacc_2015_09_099 crossref_primary_10_1016_j_ejrad_2021_109989 crossref_primary_10_1186_1532_429X_16_38 crossref_primary_10_1007_s11886_018_0965_z crossref_primary_10_1093_eurheartj_ehw136 crossref_primary_10_7759_cureus_12110 crossref_primary_10_1016_j_jacc_2020_06_063 crossref_primary_10_1093_cvr_cvp271 crossref_primary_10_1186_1745_6215_12_204 crossref_primary_10_1016_j_jacc_2013_08_724 crossref_primary_10_1161_CIRCIMAGING_117_006774 crossref_primary_10_1007_s00380_017_1080_6 crossref_primary_10_1016_j_diii_2012_05_012 crossref_primary_10_1007_s10554_009_9571_x crossref_primary_10_1016_j_jcecho_2012_04_001 crossref_primary_10_1016_j_amjcard_2013_03_013 crossref_primary_10_1161_CIRCINTERVENTIONS_109_905521 crossref_primary_10_1007_s12410_012_9123_y crossref_primary_10_1016_j_ejrad_2013_11_007 crossref_primary_10_1111_echo_12115 crossref_primary_10_1038_nrcardio_2014_75 crossref_primary_10_1016_j_amjms_2016_09_003 crossref_primary_10_1016_j_amjcard_2009_07_019 crossref_primary_10_1007_s12410_017_9398_0 crossref_primary_10_1097_MEJ_0000000000000431 crossref_primary_10_31083_j_rcm2301023 crossref_primary_10_1148_rg_335125722 crossref_primary_10_1007_s40336_023_00548_6 crossref_primary_10_1016_j_jacc_2016_01_073 crossref_primary_10_1161_JAHA_122_026923 crossref_primary_10_1016_j_rcl_2014_11_002 crossref_primary_10_3390_jcm10235677 crossref_primary_10_1016_j_ijcard_2019_05_042 crossref_primary_10_1097_MCA_0000000000000825 crossref_primary_10_1093_europace_eut289 crossref_primary_10_1016_S0140_6736_12_61064_2 crossref_primary_10_1016_j_jcmg_2015_04_018 crossref_primary_10_1016_j_cpcardiol_2009_12_002 crossref_primary_10_1007_s11886_017_0907_1 crossref_primary_10_1161_CIRCIMAGING_111_965343 crossref_primary_10_1148_radiol_11110228 crossref_primary_10_1016_j_jcmg_2019_02_025 crossref_primary_10_3389_fcvm_2022_842619 crossref_primary_10_1097_MCA_0000000000001266 crossref_primary_10_1016_j_ehj_2014_11_002 crossref_primary_10_1007_s10554_015_0673_3 crossref_primary_10_1016_j_ijcard_2025_133107 crossref_primary_10_1007_s00259_022_06015_0 crossref_primary_10_3389_fcvm_2021_794574 crossref_primary_10_1016_j_recesp_2010_09_006 crossref_primary_10_1016_j_rxeng_2014_11_003 crossref_primary_10_3390_medicina58081087 crossref_primary_10_1016_j_recesp_2010_10_008 crossref_primary_10_1016_j_ahj_2014_10_015 crossref_primary_10_1016_j_cjca_2018_10_005 crossref_primary_10_23736_S1825_859X_21_00085_2 crossref_primary_10_3390_jcm10132968 crossref_primary_10_1016_j_ajem_2011_02_015 crossref_primary_10_1161_CIRCGENETICS_116_001564 crossref_primary_10_1186_1471_2261_14_110 crossref_primary_10_3390_life13051155 crossref_primary_10_1161_JAHA_113_000226 crossref_primary_10_3390_jcm13082291 crossref_primary_10_1007_s00330_010_1963_8 crossref_primary_10_1016_j_jcmg_2010_11_015 crossref_primary_10_1093_ehjci_jes271 crossref_primary_10_1097_MD_0000000000023514 crossref_primary_10_1007_s10554_020_02136_5 crossref_primary_10_1007_s00018_023_04998_z crossref_primary_10_1016_j_rec_2014_04_007 crossref_primary_10_1097_RTI_0000000000000515 crossref_primary_10_1016_j_jradio_2011_07_026 crossref_primary_10_1161_CIRCRESAHA_111_242610 crossref_primary_10_1007_s12410_018_9448_2 crossref_primary_10_1111_j_1540_8167_2009_01503_x crossref_primary_10_1007_s10554_011_9975_2 crossref_primary_10_1371_journal_pone_0192220 crossref_primary_10_1161_CIRCIMAGING_117_007179 crossref_primary_10_1056_NEJMc2406255 crossref_primary_10_1016_j_echo_2013_09_011 crossref_primary_10_1016_j_amjcard_2020_07_060 crossref_primary_10_1002_jmri_24173 crossref_primary_10_1002_ccd_23179 crossref_primary_10_3389_fcvm_2021_724271 crossref_primary_10_1136_heartjnl_2013_303975 crossref_primary_10_3310_eme03090 crossref_primary_10_1016_j_jcct_2022_05_006 crossref_primary_10_1016_j_yjmcc_2011_01_010 crossref_primary_10_1002_jmri_25973 crossref_primary_10_1007_s10554_010_9601_8 crossref_primary_10_2217_dmt_14_53 crossref_primary_10_1007_s11818_018_0154_8 crossref_primary_10_1093_europace_euaa142 crossref_primary_10_3348_kjr_2020_0107 crossref_primary_10_1016_j_jacc_2009_07_027 crossref_primary_10_1186_s12873_020_00309_y crossref_primary_10_1093_eurheartj_eht450 crossref_primary_10_1007_s00210_022_02368_3 crossref_primary_10_1093_eurheartj_ehp095 crossref_primary_10_18087_cardio_2021_1_n1373 crossref_primary_10_1016_j_jcmg_2017_05_023 crossref_primary_10_1016_j_ahj_2010_05_035 crossref_primary_10_1016_j_yjmcc_2021_10_008 crossref_primary_10_1016_j_compbiomed_2022_106191 crossref_primary_10_1016_j_jacc_2014_06_1194 crossref_primary_10_1161_CIRCIMAGING_111_964965 crossref_primary_10_24835_1607_0763_2018_2_56_69 crossref_primary_10_1161_JAHA_116_003555 crossref_primary_10_1186_1532_429X_14_62 crossref_primary_10_1007_s00330_023_10100_9 crossref_primary_10_3390_jcm10091823 crossref_primary_10_2217_fca_13_23 crossref_primary_10_1148_radiol_10091191 crossref_primary_10_1586_erc_12_173 crossref_primary_10_1016_j_ahj_2014_04_004 crossref_primary_10_1159_000445103 crossref_primary_10_1016_j_recesp_2013_01_017 crossref_primary_10_1007_s10554_013_0239_1 crossref_primary_10_1002_jmri_25285 crossref_primary_10_1016_j_recesp_2013_04_007 crossref_primary_10_1016_j_jacc_2019_05_024 crossref_primary_10_1016_j_echo_2009_07_027 crossref_primary_10_1016_j_compbiomed_2023_107690 crossref_primary_10_1002_ccd_25961 crossref_primary_10_1136_bmjopen_2013_002813 crossref_primary_10_1093_eurheartj_ehq409 crossref_primary_10_1517_17530050903140514 crossref_primary_10_1016_j_ijcard_2012_03_056 crossref_primary_10_1093_ehjci_jeaa328 crossref_primary_10_31083_j_rcm2204178 crossref_primary_10_1097_EJA_0b013e328335fc4c crossref_primary_10_1016_j_jcin_2012_08_013 crossref_primary_10_1007_s12410_010_9023_y crossref_primary_10_1136_openhrt_2016_000535 crossref_primary_10_1016_j_jcmg_2009_03_011 crossref_primary_10_1371_journal_pone_0055477 crossref_primary_10_1161_JAHA_121_024850 crossref_primary_10_1007_s10554_017_1127_x crossref_primary_10_1253_circj_CJ_15_0606 crossref_primary_10_1186_1532_429X_15_12 crossref_primary_10_3390_jcm10091843 crossref_primary_10_1097_MD_0000000000007004 crossref_primary_10_1161_CIRCINTERVENTIONS_113_000644 crossref_primary_10_1016_j_patrec_2024_03_001 crossref_primary_10_1186_1532_429X_11_S1_P156 crossref_primary_10_1371_journal_pone_0061695 crossref_primary_10_1016_j_ejrad_2021_109590 crossref_primary_10_1016_j_rx_2014_11_008 crossref_primary_10_1016_j_atherosclerosis_2014_05_961 crossref_primary_10_1007_s11886_013_0449_0 crossref_primary_10_1016_j_echo_2021_05_016 crossref_primary_10_1016_j_pcad_2011_07_003 crossref_primary_10_15212_CVIA_2023_0027 crossref_primary_10_1016_j_ijcard_2022_08_040 crossref_primary_10_1007_s12181_012_0417_8 crossref_primary_10_1371_journal_pone_0206723 crossref_primary_10_1016_j_rec_2016_01_027 crossref_primary_10_1016_j_jmbbm_2019_103591 crossref_primary_10_1093_eurheartj_ehp219 crossref_primary_10_1161_JAHA_115_002708 crossref_primary_10_1016_j_ejrad_2011_01_088 crossref_primary_10_1186_1745_6215_15_371 crossref_primary_10_1016_j_jacc_2015_09_010 crossref_primary_10_1016_j_acvd_2015_04_002 crossref_primary_10_1016_j_jcmg_2012_12_006 crossref_primary_10_1016_j_jcmg_2014_06_012 crossref_primary_10_1016_j_jacc_2014_05_078 crossref_primary_10_1016_j_ijcard_2014_06_004 crossref_primary_10_4330_wjc_v9_i2_109 crossref_primary_10_1016_j_amjcard_2010_05_023 crossref_primary_10_1016_j_nano_2019_02_003 crossref_primary_10_1016_j_rec_2013_04_006 crossref_primary_10_1007_s10554_011_9802_9 crossref_primary_10_1161_JAHA_114_001464 crossref_primary_10_1161_CIRCEP_111_966283 crossref_primary_10_1186_s13104_015_1007_1 crossref_primary_10_1007_s10557_022_07360_w crossref_primary_10_1002_jmri_24431 crossref_primary_10_1016_j_ijcard_2018_04_017 crossref_primary_10_1016_j_amjcard_2015_02_065 crossref_primary_10_1016_j_rec_2013_01_016 crossref_primary_10_1016_j_jacc_2013_03_080 crossref_primary_10_1016_j_mri_2010_03_031 crossref_primary_10_1007_s10554_012_0155_9 crossref_primary_10_1097_CRD_0000000000000002 crossref_primary_10_1016_j_jcmg_2009_01_017 crossref_primary_10_1177_0003319720952286 crossref_primary_10_1016_j_jcmg_2010_02_004 crossref_primary_10_1186_1471_2342_10_4 crossref_primary_10_1016_j_jacc_2014_10_040 crossref_primary_10_1038_s41598_022_24855_6 crossref_primary_10_1016_j_jacc_2013_01_042 crossref_primary_10_4061_2011_605785 crossref_primary_10_1186_1532_429X_14_29 crossref_primary_10_1016_j_jacc_2008_12_017 crossref_primary_10_1259_bjr_57084479 crossref_primary_10_1007_s00395_015_0508_3 crossref_primary_10_1016_j_ahj_2019_09_005 crossref_primary_10_1007_s00330_018_5895_z crossref_primary_10_1161_CIRCIMAGING_108_835793 crossref_primary_10_1093_ehjqcco_qcv033 crossref_primary_10_1016_S0221_0363_09_74002_8 crossref_primary_10_1016_j_acvd_2015_01_008 crossref_primary_10_1161_CIRCIMAGING_112_979633 crossref_primary_10_1161_CIRCIMAGING_118_008264 crossref_primary_10_1177_2048872614556000 crossref_primary_10_1161_CIRCULATIONAHA_115_012427 crossref_primary_10_1016_j_ijcard_2012_10_050 crossref_primary_10_1016_j_amjcard_2018_05_005 crossref_primary_10_1016_j_ahj_2012_07_020 crossref_primary_10_1038_s41598_019_46117_8 crossref_primary_10_1161_CIRCULATIONAHA_117_030693 crossref_primary_10_7793_jcad_25_007 crossref_primary_10_3389_fcvm_2021_804020 crossref_primary_10_1007_s10554_015_0763_2 crossref_primary_10_2147_TCRM_S307768 crossref_primary_10_1016_j_ijcard_2016_06_025 crossref_primary_10_1016_j_jacc_2016_03_522 crossref_primary_10_1016_S1131_3587_09_71778_9 crossref_primary_10_1161_CIRCRESAHA_117_311466 crossref_primary_10_1016_j_ijcha_2020_100648 crossref_primary_10_1016_j_ijcha_2024_101339 crossref_primary_10_1115_1_4043867 crossref_primary_10_1007_s12410_015_9335_z crossref_primary_10_1536_ihj_53_263 crossref_primary_10_1016_j_amjcard_2014_08_035 crossref_primary_10_1111_cpf_12521 crossref_primary_10_1016_S0300_8932_09_70047_8 crossref_primary_10_1016_j_ijcard_2011_12_007 crossref_primary_10_1515_jim_2017_0063 crossref_primary_10_1016_j_recesp_2014_04_009 crossref_primary_10_3310_eme03010 crossref_primary_10_1007_s10554_017_1116_0 crossref_primary_10_1148_radiol_10090526 crossref_primary_10_37549_AR2430 crossref_primary_10_1016_j_jelectrocard_2015_08_035 crossref_primary_10_1111_pace_12536 crossref_primary_10_4236_wjcd_2014_412073 |
ContentType | Journal Article |
Copyright | 2008 BMJ Publishing Group and British Cardiovascular Society 2008 INIST-CNRS Copyright: 2008 2008 BMJ Publishing Group and British Cardiovascular Society |
Copyright_xml | – notice: 2008 BMJ Publishing Group and British Cardiovascular Society – notice: 2008 INIST-CNRS – notice: Copyright: 2008 2008 BMJ Publishing Group and British Cardiovascular Society |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P M2P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1136/hrt.2007.122622 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Proquest Medical Database Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-201X |
EndPage | 736 |
ExternalDocumentID | 4020734991 18070953 20321287 10_1136_hrt_2007_122622 ark_67375_NVC_753LVZS9_D heartjnl |
Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .VT 0R~ 29I 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 7X7 7~S 88E 88I 8AF 8FI 8FJ 8R4 8R5 AAFWJ AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABUWG ABVAJ ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADUGQ ADZCM AEKJL AENEX AFFNX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZFZN AZQEC BAWUL BCR BENPR BLC BLJBA BOMFT BPHCQ BTHHO BVXVI C1A CAG CCPQU COF CXRWF DIK DU5 DWQXO E3Z EBS EJD EX3 F5P FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H L7B M1P M2P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PCD PEA PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VM9 WH7 WOQ WOW X7M YFH YQY ZGI ZXP 3V. BSCLL AAYXX ACQHZ ADGHP AERUA CITATION PHGZM IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-b492t-17d0bc834a1e37d7d236db4d6da5bcf55c5cc675205b738cf5bb15310061cc33 |
IEDL.DBID | 7X7 |
ISSN | 1355-6037 1468-201X |
IngestDate | Mon Jul 21 10:10:20 EDT 2025 Fri Jul 25 08:06:30 EDT 2025 Thu Apr 03 07:05:50 EDT 2025 Mon Jul 21 09:11:48 EDT 2025 Tue Jul 01 02:03:41 EDT 2025 Thu Apr 24 23:05:34 EDT 2025 Wed Oct 30 09:30:18 EDT 2024 Thu Apr 24 22:50:02 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Heart Prognosis Infarct Predictor Magnetic resonance Size Prediction Index Systolic volume Nuclear magnetic resonance imaging Left ventricle Prospective Cohort study Medical imagery Evolution Ventricular ejection End Circulatory system Hemodynamics Cardiology Predictive factor Contrast media Ejection fraction |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b492t-17d0bc834a1e37d7d236db4d6da5bcf55c5cc675205b738cf5bb15310061cc33 |
Notes | PMID:18070953 local:heartjnl;94/6/730 A video view of figure 1 is published online only athttp://heart.bmj.com/content/vol94/issue6 href:heartjnl-94-730.pdf ark:/67375/NVC-753LVZS9-D istex:93786D50F1073C1770D8D457FF426CF5891100D2 ArticleID:ht122622 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
PMID | 18070953 |
PQID | 1780692731 |
PQPubID | 2041068 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_70723527 proquest_journals_1780692731 pubmed_primary_18070953 pascalfrancis_primary_20321287 crossref_primary_10_1136_hrt_2007_122622 crossref_citationtrail_10_1136_hrt_2007_122622 istex_primary_ark_67375_NVC_753LVZS9_D bmj_primary_10_1136_hrt_2007_122622 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-06-01 |
PublicationDateYYYYMMDD | 2008-06-01 |
PublicationDate_xml | – month: 06 year: 2008 text: 2008-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Heart (British Cardiac Society) |
PublicationTitleAlternate | Heart |
PublicationYear | 2008 |
Publisher | BMJ Publishing Group Ltd and British Cardiovascular Society BMJ BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group Ltd and British Cardiovascular Society – name: BMJ – name: BMJ Publishing Group LTD |
References | Hombach, Grebe, Merkle 2005; 26 Kim, Wu, Rafael, Chen 2000; 343 Lima, Judd, Bazille 1995; 92 Wu, Zerhouni, Judd 1998; 97 Grothues, Moon, Bellenger 2004; 147 Ibrahim, Bulow, Hackl 2007; 49 Choi, Kim, Gubernikoff 2001; 104 Pfeffer 1995; 46 Gaudron, Eilles, Kugler 1993; 87 Marcassa, Galli, Temporelli 1995; 25 Wagner, Mahrholdt, Holly 2003; 361 Weiss, Marino, Shapiro 1991; 68 St John Sutton, Lee, Rouleau 2003; 107 Rahimtoola 1989; 117 Bolognese, Neskovic, Parodi 2002; 106 Burns, Gibbons, Yi 2002; 39 Wu, Judd, Vargas 2001; 357 Braunwald, Kloner 1982; 66 Simonetti, Kim, Fieno 2001; 218 White, Norris, Brown 1987; 76 Miller, Christian, Hopfenspirger 1995; 92 Cerqueira, Weissman, Dilsizian 2002; 105 Tarantini, Razzolini, Cacciavillani 2006; 98 Coletta, Sestili, Seccareccia 2003; 89 Gibbons, Valeti, Araoz 2004; 44 |
References_xml | – volume: 89 start-page: 1138 year: 2003 article-title: Influence of contractile reserve and inducible ischaemia on left ventricular remodelling after acute myocardial infarction. publication-title: Heart – volume: 357 start-page: 21 year: 2001 article-title: Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. publication-title: Lancet – volume: 147 start-page: 218 year: 2004 article-title: Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. publication-title: Am Heart J – volume: 97 start-page: 765 year: 1998 article-title: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. publication-title: Circulation – volume: 104 start-page: 1101 year: 2001 article-title: Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. publication-title: Circulation – volume: 361 start-page: 374 year: 2003 article-title: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. publication-title: Lancet – volume: 105 start-page: 539 year: 2002 article-title: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. publication-title: Circulation – volume: 343 start-page: 1445 year: 2000 article-title: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. publication-title: N Engl J Med – volume: 92 start-page: 334 year: 1995 article-title: Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. publication-title: Circulation – volume: 106 start-page: 2351 year: 2002 article-title: Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. publication-title: Circulation – volume: 49 start-page: 208 year: 2007 article-title: Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. publication-title: J Am Coll Cardiol – volume: 92 start-page: 1117 year: 1995 article-title: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. publication-title: Circulation – volume: 87 start-page: 755 year: 1993 article-title: Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. publication-title: Circulation – volume: 76 start-page: 44 year: 1987 article-title: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. publication-title: Circulation – volume: 117 start-page: 211 year: 1989 article-title: The hibernating myocardium. publication-title: Am Heart J – volume: 46 start-page: 455 year: 1995 article-title: Left ventricular remodeling after acute myocardial infarction. publication-title: Annu Rev Med – volume: 68 start-page: 35D year: 1991 article-title: Myocardial infarct expansion: recognition, significance and pathology. publication-title: Am J Cardiol – volume: 66 start-page: 1146 year: 1982 article-title: The stunned myocardium: prolonged, postischemic ventricular dysfunction. publication-title: Circulation – volume: 26 start-page: 549 year: 2005 article-title: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. publication-title: Eur Heart J – volume: 39 start-page: 30 year: 2002 article-title: The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. publication-title: J Am Coll Cardiol – volume: 218 start-page: 215 year: 2001 article-title: An improved MR imaging technique for the visualization of myocardial infarction. publication-title: Radiology – volume: 107 start-page: 2577 year: 2003 article-title: Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. publication-title: Circulation – volume: 25 start-page: 590 year: 1995 article-title: Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction. publication-title: J Am Coll Cardiol – volume: 44 start-page: 1533 year: 2004 article-title: The quantification of infarct size. publication-title: J Am Coll Cardiol – volume: 98 start-page: 1033 year: 2006 article-title: Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. publication-title: Am J Cardiol |
SSID | ssj0004986 |
Score | 2.4323082 |
Snippet | Objectives:Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial... Objectives: Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial... Ejection fraction (EF) and end-systolic volume index (ESVI) are established predictors of outcomes following ST-segment elevation myocardial infarction... |
SourceID | proquest pubmed pascalfrancis crossref istex bmj |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 730 |
SubjectTerms | Biological and medical sciences Cardiology. Vascular system Cardiovascular system Clinical outcomes Contrast Media Coronary Angiography Epidemiologic Methods Female Gangrene Heart attacks Humans Investigative techniques of hemodynamics Investigative techniques, diagnostic techniques (general aspects) Magnetic Resonance Imaging - methods Male Medical sciences Middle Aged Mortality Multivariate analysis Myocardial Infarction - pathology Myocardial Infarction - physiopathology Patients Stroke Volume - physiology Systole - physiology Ventricular Dysfunction, Left - physiopathology Ventricular Remodeling - physiology |
Title | Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study |
URI | http://heart.bmj.com/content/94/6/730.full https://api.istex.fr/ark:/67375/NVC-753LVZS9-D/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/18070953 https://www.proquest.com/docview/1780692731 https://www.proquest.com/docview/70723527 |
Volume | 94 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELZoV0JcEO-mLctIIMQlNImTOOGCoLQqiK4QlGrFxbIdpw_aZEmyEvDn-GvMONld9VC4btZW5JnM29_H2LM0RieiQu2Xhqd-LJT2M_Rrfom-0uiI61hTR_dwkh58jT9Mk-lQcGuHscqFTXSGuqgN1ch3QpEFaY7ONnw9--ETaxR1VwcKjTU2Iugy0moxFat7kbljegzRp_ppwMUA7RPydOe06Xr8whDjD2LOXdOX51d804iO-SfNSqoWj6vseS6uD0SdQ9q_w24PkSS86UV_l92w1T1283Dold9nf95XJWpxB-3Zbwv6F7ipdNV2YKtT1_cH49TDwKU6qegyI2DuXRMCh4WzFhS0VCc_sQ3MGtoW03OoS6jnHR6ZbYGq7nBhyw5oaNJVElUD9txNd1VQNv2lCcBltip8Ao0mFGLoLSI4oMZXuHe9uO4JRNfb4BsT5u0DdrS_d7R74A90Db6O86jzQ1EE2mQ8VqHlohBFxNNCx0VaqESbMklMYgzmJ1GQaMEz_EVrtLchRVHGcP6QrVd1ZTcY6NSIIAmMxdA_xgxLFxi1RSE3ZWZsoBOPPUVpyVmPxyFdHsNTiTIlVk0he5l67OVCmtIMgOfEu3Fx_YIXywX_3fu5U4_l_1TznUbkRCInx7sSc8CPx9--5PKdx8ZX9Ge5gJjrMTYQHtteKJQczEcrV8rusSfLx_jhUzdHVbaet1IEIsLoGTd41Kvh6p0ztON5wjf_vfUWu9UPv1BJaZutd83cPsYIq9Nj9xmN2ejt3uTT57_pjycZ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKKwEXxJuF0o7EQ1xCkziJs0gIoZZql-7uhaVa9WLFjtMHbbIkqaD8J34Df40ZJ9lVD4VTr0k8sjLj-WbG82DsZRQgiCSecjLNIycQiXJixDUnQ6zUyucqUHSjO55Eg6_B51k4W2G_u1oYSqvsdKJV1GmhKUa-5YnYjfoItt6H-XeHpkbR7Wo3QqMRiz1z8QNdtur9cAf5-8r3dz9NtwdOO1XAUUHfrx1PpK7SMQ8Sz3CRitTnUaqCNEqTUOksDHWoNZrRvhsqwWN8ohSqBY_AXmuKf6LGX0PcdcnXEzOxLMPs28GSHkK4E7lctJ2EPB5tHZV10y7RQ3OHBvXeUGcnl6Bwjbj6k1Izkwq5kzVjNa62ey3-7d5ld1rDFT42knaPrZj8Prs5bq_mH7A_wzzDv1NDdfzLgLoAmwSfVDWY_MimGYC20qjhLDnMqXYS0NUvqOGHgeMKEqgoLH9oSpiXRLYuSigyKM5r5JCpgIL8cGqyGihH0wYukxLMiU0myyErmxoNwGUmTx3qUU1Nj6FRwGD7Qr5D2kVXXQo0HbjEHVOL3Ydseh18fMRW8yI3TxioSAs3dLVBTyNAh06laCT6HtdZrI2rwh57gdyS86b9h7RuE48k8pSGeArZ8LTH3nbclLrtr05jPk6vXvBmseC_tF9b8Vh8l5TfKCNPhHKyvy3R5RztH3zpy50e27gkP4sFvsvRSIlFj613AiVbbVXJ5dnqsc3Fa9QzdHmU5KY4r6RwhY_GOhJ43Ijhcs8xwkY_5E__TXqT3RpMxyM5Gk72nrHbTd4NRbPW2WpdnpvnaNzVasMeKWDymo_wXyaqYeA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VRKq4IN6ElnYkHuJiYnttr4OEEDSNGtpGFZSq4rLyrtd928F2BOWfceKvMeNHoh4Kp15t72jlmZ3XfjPD2IvAQyMSOcpKNA8sT0TKCtGuWQnaSq1crjxFN7q7k2Drq_fp0D9cYr_bWhiCVbY6sVLUcaYpR953RGgHAzS2Tj9pYBF7w9H76XeLJkjRTWs7TqMWkW1z-QPDt-LdeIi8fum6o839jS2rmTBgKW_glpYjYlvpkHuRY7iIRezyIFZeHMSRr3Ti-9rXGl1q1_aV4CE-UQpVhEOGX2vKhaL27woKijqs-3Fzsvd5UZQ5qMZMOmjQrcDmoukr5PCgf5yXdfNEB50fGtt7S12cXjGMXeLxTwJqRgXyKqmHbFzvBVfWcHSX3WncWPhQy909tmTS-2x5t7mof8D-jNME_08JxckvA-oSKkh8VJRg0uMKdAC6kk0NF9FRSpWUgIF_Ru0_DJwUEEFBSfojk8M0J7JllkOWQDYrkV-mAEr5w7lJSiDEZpXGjHIwpxW0LIUkrys2AJeZNLaoYzW1QIZaHUPVJfIt0s7aWlOgWcE57pga7j5k-zfByUesk2apecJABVrYvq0Nxh0ehncqRpfRdbhOQm1s5ffYc-SWnNbNQGQVRPFAIk9ppKeQNU977E3LTambbus09OP8-gWv5wv-S_tVJR7z76L8jPB5wpeTgw2JAejOwbcvAznssbUr8jNf4NocXZZQ9NhqK1Cy0V2FXJy0Hlufv0atQ1dJUWqyWSGFLVx03ZHA41oMF3sO0YgMfP7036TX2TIeX7kznmyvsNs1CIdSW6usU-Yz8ww9vVKtNWcKmLzhU_wXpSJnew |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Infarct+size+by+contrast+enhanced+cardiac+magnetic+resonance+is+a+stronger+predictor+of+outcomes+than+left+ventricular+ejection+fraction+or+end-systolic+volume+index%3A+prospective+cohort+study&rft.jtitle=Heart+%28British+Cardiac+Society%29&rft.au=Wu%2C+E&rft.au=Ortiz%2C+J+T&rft.au=Tejedor%2C+P&rft.au=Lee%2C+D+C&rft.date=2008-06-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=1355-6037&rft.eissn=1468-201X&rft.volume=94&rft.issue=6&rft.spage=730&rft_id=info:doi/10.1136%2Fhrt.2007.122622&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4020734991 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-6037&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-6037&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-6037&client=summon |